Results 171 to 180 of about 15,740 (203)

Management of relapsed/refractory AL amyloidosis. [PDF]

Blood Adv
Ling J, Sidiqi MH, Gertz M.
europepmc   +1 more source

Budget Impact of Venetoclax for Newly Diagnosed Patients with Acute Myeloid Leukemia Aged ≥ 75 Years or with Comorbidities Precluding Intensive Chemotherapy in the United States. [PDF]

Adv Ther
Xu Y, Nguyen J, Miu K, Lin CW, Montez M, Chai X, Chen X, LeBlanc TW.   +7 more
europepmc   +1 more source

Real-World Treatment Patterns and Safety Outcomes of Targeted Therapies in a Single-Center Chronic Lymphocytic Leukemia Cohort. [PDF]

Medicina (Kaunas)
Jeral Evinç S, Eyüpler Akmercan Ç, Ercan T, Arıkan F, Mengüç MU, Toptaş T, Atagündüz I, Tuğlular T, Yılmaz AF.   +8 more
europepmc   +1 more source

Venetoclax Plus Hypomethylating Agents for Treatment-Naïve Myelodysplastic Syndromes with Increased Blasts: A Prospective Multicenter Cohort Study. [PDF]

Blood Lymphat Cancer
Zhao N, Zhu L, Hu X, Tong J, Ge H, Ye L, Zhu X, Gai C, Feng Y, Zhang L, Wang L, Sun G, Xue L, Zhu X, Zheng C.   +14 more
europepmc   +1 more source

Genomic mechanisms of resistance to venetoclax in multiple myeloma with t(11;14)(CCND1;IGH).

Blood
Kaddoura M, Wiedmeier-Nutor JE, Gupta VA, Jelinek T, Ziccheddu B, Shivaram S, Tang H, Owens RW, Sevcikova T, Fonseca R, Durante M, Diamond B, Zhao L, Zhu YX, Shi CX, Matulis SM, Mitsiades CS, Landgren O, Usmani S, Hajek R, Chesi M, Bergsagel PL, Braggio E, Boise LH, Fonseca R, Kumar S, Maura F, Baughn LB.   +27 more
europepmc   +1 more source

Venetoclax-Based Regimens in Chronic Myelomonocytic Leukemia: A Systematic Review and Meta-Analysis.

Acta Haematol
Abdulgayoom M, Afana MS, Saleh LH, Manthiri AA, Aweer NA, Bakheet M, Al-Mashdali AF, Mohamed SF.   +7 more
europepmc   +1 more source

Venetoclax

Onkologische Welt, 2023
Bereits im Jahr 1984 wurde das Protein BCL-2 als relevant für das Tumorgeschehen identifiziert, rekapitulierte Dr. Mary Ann Anderson, Melbourne (Australien), die Entwicklungsgeschichte von Venetoclax. Doch es sollten noch einige Jahrzehnte bis zur Marktreife der effektiven Substanz vergehen.
  +7 more sources

Venetoclax

Reactions Weekly, 2021
  +8 more sources

Venetoclax

Reactions Weekly, 2022
  +8 more sources